U.S. Cord Blood Banking Services Market Size to Surpass USD 25.41 Bn by 2034
The U.S. cord blood banking services market size was valued at USD 8.50 billion in 2024 and is expected to be worth around USD 25.41 billion by 2034, growing at a CAGR of 11.57 during the forecast period from 2025 to 2034. Technological advancement and rising consumer awareness drive the U.S. cord blood banking services market.
The growth of the U.S. market for cord blood banking services is perhaps due to the increasing applications of cord blood and stem cells for managing hereditary disorders and chronic diseases. Increased awareness of collective availability of service providers, increased health coverage, and so on aspects of growth. The United States has a mature market, with higher consumer spending and competitive pricing. The application of umbilical cord blood in chronic illnesses, such as those relating to bone marrow disorders, growth-inhibiting cancer, blood diseases, liver pathologies, and immunodeficiency syndromes, could generate driving demand for these collections. This effect will considerably benefit the market in the coming years.
The growing incidence of cancers combined with the evolution of stem cell therapy is likely to create a further positive boom for the industry. The U.S. cord blood banking services industry is expected to sustain consistent growth with increased awareness of advances in technology and diversified service offerings.
| Report Coverage | Details |
| Market Size in 2025 | USD 9.49 Billion |
| Market Size by 2034 | USD 25.41 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 11.57% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Bank Type, Component, States |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Key Companies Profiled | California Cryobank, StemCyte Inc., Cryo-Cell International Inc., Lifeforce Cryobank Sciences Inc., Stem Cell Cryobank Inc., Norton Healthcare Viacord, MiracleCord Inc., New Jersey Cord Blood Bank, Carter BloodCare. |
Driver
Growing Awareness and Medical Advancements Fuel Cord Blood Banking Market
The cord blood banking market is on the rise due to increasing awareness of stem cell therapy and its possible life-saving applications. Public awareness campaigns, educational programs, and professional health practitioners' guidance are crucial in affirming the benefits of cord blood stem cells for therapeutic use in autoimmune disorders, cancers, and hematological diseases. The need for cord blood banking services stems from the very fact that these therapies are being recognized by the medical community. The growing field of personalized medicine is also acting as a catalyst for demand since parents tend to consider their child's cord blood as a valuable biological resource that could tailor interventions in case their child ever gets sick. This is valid since there are accelerating studies on regenerative medicine that make the services more promising in the eyes of society. All of the above contribute to the growth of the cord blood banking market.
Opportunity
Technological Advancements Creating Opportunities in Cord Blood Banking
Emerging technologies are revolutionizing cord blood banking, advancing both the processing and storage of stem cells, as well as their therapeutic uses. Increasingly automated processing facilities save time and resources; cryopreservation techniques ensure long-term storage and cell viability maintenance. Quality control systems assure consistency in processing. There is a growing trend toward the use of cord blood stem cells for hematopoietic stem cell transplantation as treatments for blood disorders and malignancies, as well as for some immune disorders. Research is also focusing on the roles of cord blood stem cells in regenerative medicine and tissue repair, as well as gene therapy. While cord tissue banking where mesenchymal stem cells (MSCs) are abundant is gaining popularity for its regenerative potential and easy availability, newer techniques that proliferate cord blood stem cells are increasing their accessibility to potential uses.
Restraint
Cost Challenges in Cord Blood Banking
The cord blood banking industry has witnessed huge challenges regarding cost. These are worst in price-sensitive regions. Private banks have implications of high upfront and ongoing costs with respect to collection, processing, cryopreservation, and even annual storage. It generally turns out to be a very costly venture for most families. The reality of financial load discourages many in very poor economies and among those who do not have much disposable income. Public banks also make their cord blood collection services free. However, they face many sustainability and funding challenges, as well as the diversity of their donors. Private banks do allow exclusive access to stored cord blood. However, that privilege comes at a cost, which, unfortunately, excludes a large part of the population. Complex maintenance and storage requirements call for specialized equipment, trained staff, and meticulous monitoring, and this adds to the cost.
The private banks segment dominated the market as it has a very large customer base and advanced marketing strategies. They provide premium services and advanced facilities with personalized care that attracts all classes of customers. Higher costs resulting from cord blood collection and retention add to their revenue. They charge exorbitant fees for the specialized processing and associated long-term storage and enhanced service options through which private banks entrap customers in search of dependable, high-quality offerings. The hybrid banking segment is expected to witness a rapid surge in growth and combine the features of public and private cord blood banking, offering different benefits such as donation and family banking. This model is proving to be more popular among private banks and focuses on StemCyte, Celebration Stem Cell Centre, Core 23 BioBank, and New Jersey Cord Blood Bank, promoting the global accessibility of cord blood transplants along with offering more personalized banking services. The merging of public-private systems is what is mainly driving the growth of the hybrid bank.
The cord blood segment covers the bulk of the U.S. market for cord blood banking services due to the rising demand for umbilical cord blood applications in regenerative medical biology and treatment of chronic diseases. Contributing factors include the increasing numbers of umbilical cord blood providers and the number of births in the U.S. The fastest growth for the cord tissue segment is expected due to progress in research about its applications in Parkinson’s disease, multiple sclerosis, Type 1 diabetes, rheumatoid arthritis, and even cerebral palsy. Awareness of tissue storage benefits is expected to spur further market expansion.
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. cord blood banking services market
By Bank Type Scope
By Component Scope
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers